Comparing Laparoscopic and Open Surgery for Pancreatic Carcinoma

Background: Pancreatic cancer (PC) is one of the most aggressive malignant neoplasms with poor outcomes. Pancreatoduodenectomy (PD) is the only curative treatment for PC. Minimally invasive surgery has been progressively developed, first with the advent of hybrid-laparoscopy and recently with the total laparoscopy surgeries, but a number of issues are currently being debated, including the superiority between total laparoscopic pancreaticoduodenectomy (TLPD)and the open pancreaticoduodenectomy (OPD). Studies comparing these two surgery techniques are merging and randomized controlled trials (R

Trial Details

NCT ID
NCT03785743
Phase
NA
Sponsor
Tongji Hospital
Status
RECRUITING
Cancer Type
Pancreatic Cancer
Interventions
  • TLPD Surgery
  • OPD Surgery
Locations (sample)
  • Wuhan, Hubei, China|30.58333,114.26667

Key Eligibility Criteria

  • Age between 18 years and 75 years.
  • Histologically confirmed PDAC or clinically diagnosed PDAC by an MDT without histopathologic evidence.
  • Patients feasible to undergo both LPD and OPD according to MDT evaluations.
  • Patients understanding and willing to comply with this trial.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Pancreatic Cancer Trials on Trialify →